SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 253 filers reported holding SAGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,049,000 | -15.6% | 38,500 | -26.7% | 1.38% | -18.4% |
| Q1 2019 | $8,350,000 | +141.1% | 52,500 | +144.2% | 1.70% | +43.1% |
| Q1 2018 | $3,463,000 | +250.5% | 21,500 | +258.3% | 1.19% | +210.5% |
| Q4 2017 | $988,000 | +5.7% | 6,000 | -60.0% | 0.38% | +42.0% |
| Q3 2017 | $935,000 | +67.9% | 15,000 | +114.3% | 0.27% | +37.9% |
| Q2 2017 | $557,000 | -12.8% | 7,000 | -22.2% | 0.20% | -37.7% |
| Q1 2017 | $639,000 | +36.8% | 9,000 | +12.5% | 0.31% | +30.4% |
| Q4 2015 | $467,000 | -80.6% | 8,000 | -75.8% | 0.24% | -77.9% |
| Q2 2015 | $2,409,000 | – | 33,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |